Dr. Edwin P. Alyea

Dr. Edwin P. Alyea inyanzvi yekurapa varwere vegomarara reropa vari kufunga nezve stem cell kana kuti bone mwongo. Kwemakore makumi maviri apfuura, kwave nekufambira mberi kukuru mukusimwa, izvo zvakakonzera mhedzisiro iri nani. Kufambira mberi uku kunosanganisira kugona kushandisa yakaderera chemotherapy dosages kuderedza chepfu muvarwere, pamwe nenzira dzekudzikisa mukana wekudzoka zvakare. Ndiri kufarira kushandisa mishonga yemanovel uye matekiniki ekuvandudza mhedzisiro inotevera stem cell transplantation yeropa. Zvakakosha kubatirana nevarwere kutsanangura zvinangwa zvavo zvekurapa uye nzira yakanaka yekuita. Kwemakore akawanda zvichitevera kutamiswa kwavo, ndanga ndichida kushanda nevarwere nemhuri dzavo.

Bhodhi Certification

American Board yeInternal Med, Medical Oncology

Fellowship

Medical Oncology, Dana-Farber Cancer Institute (Massachusetts), 1992-1995

Residency

Mushonga Wemukati, Brigham uye Chipatara chevakadzi (Massachusetts), 1989-1992

dzidzo

MD, Duke University, 1989

• Adult Bone Marrow uye Stem Cell Transplant
• Autologous Transplant
• Allogeneic Transplant
• Syngeneic Transplant

• Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.” J Clin Oncol 38, kwete. 12 (Kubvumbi 20, 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011.
• Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” J Clin Oncol 35, kwete. 36 (Zvita 20, 2017): 4003-11. https://doi.org/10.1200/JCO.2017.75.8177.
• Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” Biol Ropa Marrow Kubika 23, kwete. 5 (Chivabvu 2017): 767-75. https://doi.org/10.1016/j.bbmt.2017.01.078.
• Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” J Clin Oncol 35, kwete. 11 (Kubvumbi 10, 2017): 1154–61. https://doi.org/10.1200/JCO.2016.70.7091.
• Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” J Clin Oncol 34, kwete. 16 (June 1, 2016): 1864-71. https://doi.org/10.1200/JCO.2015.65.0515.
• Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” J Clin Oncol 33, kwete. 35 (Zvita 10, 2015): 4167-75. https://doi.org/10.1200/JCO.2015.62.7273.
• Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” Biol Ropa Marrow Kubika 20, kwete. 5 (Chivabvu 2014): 668-75. https://doi.org/10.1016/j.bbmt.2014.01.021.
• Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” ropa 122, kwete. 8 (Nyamavhuvhu 22, 2013): 1510-17. https://doi.org/10.1182/blood-2013-04-495895.
• Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” Transplantation 92, kwete. 3 (Nyamavhuvhu 15, 2011): 359-65. https://doi.org/10.1097/TP.0b013e3182244cc3.